BIOCRYST PHARMACEUTICALS, INC. Deferred Tax Assets, Unrealized Currency Losses
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Deferred Tax Assets, Unrealized Currency Losses of -$2.29 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses · last filed 2015-03-02
- 2014-12-31: Deferred Tax Assets, Unrealized Currency Losses -$2.29M.
- 2013-12-31: Deferred Tax Assets, Unrealized Currency Losses -$207.00K.
- 2012-12-31: Deferred Tax Assets, Unrealized Currency Losses $1.85M.
- 2011-12-31: Deferred Tax Assets, Unrealized Currency Losses $1.58M.
| Period end | Deferred Tax Assets, Unrealized Currency Losses |
|---|---|
| 2014-12-31 | -$2.29M 10-K · filed 2015-03-02 |
| 2013-12-31 | -$207.00K 10-K · filed 2015-03-02 |
| 2012-12-31 | $1.85M 10-K · filed 2014-03-10 |
| 2011-12-31 | $1.58M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |